Jimmy,
Loved the book idea hahah
Ok timelines...officially prob the latest is this:
Thats from here:
https://paradigmbiopharma.com/wp-content/uploads/2023/04/PAR_Edison-Update-April-2023.pdfTo compliment that I would suggest (only my thoughts, could be totally wrong, dont rely on it):
1) Canine soon, perhaps in next month or so...maybe less?
Gives us good insight on 3 year observations. Good data to accumulate behind the scenes
2) Bio conference 3rd June. Again, more for behind the scenes chats. Yes PAR have been at a few of these type meetings but they all help to get the good word out and you don't know what new interested parties might step up and start to get serious as we tick off milestones and power through the trials.
3) FDA and EMA discussions, hopefully Q3. Once again it will be behind the scenes but any changes here could be material and could be exciting, indeed watch this space
4) MPS I read out, may not be for a few more months but again will show progress and give us some additional insight
5) MPS VI readout, perhaps at the end of the year. This will also be very important data.
6) Minimal Effective Dose determination and Conclusion to Part 1 002. Should be Q3 sometime?
Lots to come...share price dawdles but we progress regardless...keeping going PAR
My views
(20min delay)